This suggests that SHP2 may act as a negative regulator in these pathways, counteracting the effects of CD244 and potentially alleviating its pro-inflammatory and pro-apoptotic activities in the context of COPD. The gene discussed is PTPN11; the disease is chronic obstructive pulmonary disease.